Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5049)
All Articles published online
|
Jan 21, 2012 (publication date) through Dec 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Thummarati P, Wijitburaphat S, Prasopthum A, Menakongka A, Sripa B, Tohtong R, Suthiphongchai T. High level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis. World J Gastroenterol 2012; 18(3): 244-250 [PMID: 22294827 DOI: 10.3748/wjg.v18.i3.244] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i3/244.htm |
| Number | Citing Articles |
| 1 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 605 doi: 10.1007/978-3-319-26956-6_31
|
| 2 |
Mei‐Di Hu, Ling‐Hua Jia, Ming‐long Wang. PLAU contributes to the development of cholangiocarcinoma via activating NF‐κB signaling pathway. Cell Biology International 2023; 47(8): 1381 doi: 10.1002/cbin.12025
|
| 3 |
Jia‑Ju Lu, Hong Guo, Bo Gao, Yun Zhang, Qing‑Ling Lin, Jiang Shi, Jing‑Jing Liu, Jian Liu. Prognostic value of urokinase plasminogen activator system in non‑small cell lung cancer: A systematic review and meta‑analysis. Molecular and Clinical Oncology 2017; doi: 10.3892/mco.2017.1484
|
| 4 |
Kittiya Islam, Brinda Balasubramanian, Simran Venkatraman, Parichut Thummarati, Janpen Tunganuntarat, Nut Phueakphud, Phongthon Kanjanasirirat, Tanawadee Khumpanied, Pornparn Kongpracha, Yingpinyapat Kittirat, Rutaiwan Tohtong, Tavan Janvilisri, Patompon Wongtrakoongate, Suparerk Borwornpinyo, Nisana Namwat, Tuangporn Suthiphongchai. Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-48798-8
|
| 5 |
Xing-Dong Cai, Li Che, Jia-Xin Lin, Shuai Huang, Jiong Li, Xiao-Yan Liu, Xing-Fei Pan, Qin-Qin Wang, Li Chen, Ming-Juan Lin, Zhi-Hong Huang, Hong-Ming Ma, Yi Wu, Sheng-Ming Liu, Yan-Bin Zhou. Krüppel-like factor 17 inhibits urokinase plasminogen activator gene expression to suppress cell invasion through the Src/p38/MAPK signaling pathway in human lung adenocarcinoma. Oncotarget 2017; 8(24): 38743 doi: 10.18632/oncotarget.17020
|
| 6 |
MANMAN SU, WEIQIN CHANG, MANHUA CUI, YANG LIN, SHUYING WU, TIANMIN XU. Expression and anticancer activity analysis of recombinant human uPA1–43-melittin. International Journal of Oncology 2015; 46(2): 619 doi: 10.3892/ijo.2014.2750
|
| 7 |
Zoi Piperigkou, Dimitra Manou, Konstantina Karamanou, Achilleas D. Theocharis. Proteases and Cancer. Methods in Molecular Biology 2018; 1731: 325 doi: 10.1007/978-1-4939-7595-2_27
|
| 8 |
Zachary J. Brown, Satyajit Patwardhan, Joal Bean, Timothy M. Pawlik. Molecular diagnostics and biomarkers in cholangiocarcinoma. Surgical Oncology 2022; 44: 101851 doi: 10.1016/j.suronc.2022.101851
|
| 9 |
Lavinia-Patricia Mocan, Maria Ilieș, Carmen Stanca Melincovici, Mihaela Spârchez, Rareș Crăciun, Iuliana Nenu, Adelina Horhat, Cristian Tefas, Zeno Spârchez, Cristina Adela Iuga, Tudor Mocan, Carmen Mihaela Mihu. Novel approaches in search for biomarkers of cholangiocarcinoma. World Journal of Gastroenterology 2022; 28(15): 1508-1525 doi: 10.3748/wjg.v28.i15.1508
|
| 10 |
MANMAN SU, WEIQIN CHANG, KUN ZHANG, MANHUA CUI, SHUYING WU, TIANMIN XU. Expression and purification of recombinant ATF-mellitin, a new type fusion protein targeting ovarian cancer cells, in P. pastoris. Oncology Reports 2016; 35(2): 1179 doi: 10.3892/or.2015.4448
|
| 11 |
Ali Mohammad Alizadeh, Sadaf Shiri, Sadaf Farsinejad. Metastasis review: from bench to bedside. Tumor Biology 2014; 35(9): 8483 doi: 10.1007/s13277-014-2421-z
|
| 12 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_31-1
|
| 13 |
YOU CHAO DAI, SI MIN YANG, XIN WANG, YONG JUN ZHOU, GAN HOU, DI NAN HUANG. Antitumor effect and mechanism of action of a tumor-targeting recombinant human tumor necrosis factor-α fusion protein mediated by urokinase. Molecular Medicine Reports 2015; 11(6): 4333 doi: 10.3892/mmr.2015.3313
|
| 14 |
MANMAN SU, WEIQIN CHANG, DINGDING WANG, MANHUA CUI, YANG LIN, SHUYING WU, TIANMIN XU. Expression and activity analysis of a new fusion protein targeting ovarian cancer cells. Oncology Reports 2015; 34(3): 1337 doi: 10.3892/or.2015.4118
|
| 15 |
Sadaf Vahdat, Seyed Ahmad Mousavi, Gholamreza Omrani, Maziar Gholampour, Fattah Sotoodehnejadnematalahi, Zaniar Ghazizadeh, Javad Gharechahi, Hossein Baharvand, Ghasem Hosseini Salekdeh, Nasser Aghdami. Cellular and Molecular Characterization of Human Cardiac Stem Cells Reveals Key Features Essential for Their Function and Safety. Stem Cells and Development 2015; 24(12): 1390 doi: 10.1089/scd.2014.0222
|
| 16 |
Sandra Pavicevic, Sophie Reichelt, Deniz Uluk, Isabella Lurje, Cornelius Engelmann, Dominik P. Modest, Uwe Pelzer, Felix Krenzien, Nathanael Raschzok, Christian Benzing, Igor M. Sauer, Sebastian Stintzing, Frank Tacke, Wenzel Schöning, Moritz Schmelzle, Johann Pratschke, Georg Lurje. Prognostic and Predictive Molecular Markers in Cholangiocarcinoma. Cancers 2022; 14(4): 1026 doi: 10.3390/cancers14041026
|
| 17 |
Andrey D. Dolbnya, Igor A. Popov, Stanislav I. Pekov. Molecular Biomarkers in Cholangiocarcinoma: Focus on Bile. Current Topics in Medicinal Chemistry 2024; 24(8): 722 doi: 10.2174/0115680266290367240130054142
|
| 18 |
L A Walsh, D M Roy, M Reyngold, D Giri, A Snyder, S Turcan, C R Badwe, J Lyman, J Bromberg, T A King, T A Chan. RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch. Oncogene 2015; 34(17): 2189 doi: 10.1038/onc.2014.175
|
| 19 |
Mohammad Hassan Baig, Mohd Adil, Rosina Khan, Surendar Dhadi, Khurshid Ahmad, Gulam Rabbani, Tufail Bashir, Mohammad Azhar Imran, Fohad Mabood Husain, Eun Ju Lee, Mohammad Amjad Kamal, Inho Choi. Enzyme targeting strategies for prevention and treatment of cancer: Implications for cancer therapy. Seminars in Cancer Biology 2019; 56: 1 doi: 10.1016/j.semcancer.2017.12.003
|
| 20 |
JUNJI MA, JUNLI SHI, DONGQIANG ZHAO, LIJUAN CHENG, WENBIN WANG, FANGFANG LI, XIAOYU JIANG, HUIQING JIANG. Raf kinase inhibitor protein inhibits cholangiocarcinoma cell metastasis by downregulating matrix metalloproteinase 9 and upregulating tissue inhibitor of metalloproteinase 4 expression. Oncology Letters 2015; 9(1): 15 doi: 10.3892/ol.2014.2637
|
| 21 |
Sven H. Loosen, Annemarie Breuer, Frank Tacke, Jakob N. Kather, Joao Gorgulho, Patrick H. Alizai, Jan Bednarsch, Anjali A. Roeth, Georg Lurje, Sophia M. Schmitz, Jonathan F. Brozat, Pia Paffenholz, Mihael Vucur, Thomas Ritz, Alexander Koch, Christian Trautwein, Tom F. Ulmer, Christoph Roderburg, Thomas Longerich, Ulf P. Neumann, Tom Luedde. Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer. JHEP Reports 2020; 2(2): 100080 doi: 10.1016/j.jhepr.2020.100080
|
| 22 |
|
| 23 |
Chao-Bin Yeh, Ming-Ju Hsieh, Chiao-Wen Lin, Hui-Ling Chiou, Pen-Yuan Lin, Tzy-Yen Chen, Shun-Fa Yang, Rakesh K. Srivastava. The Antimetastatic Effects of Resveratrol on Hepatocellular Carcinoma through the Downregulation of a Metastasis-Associated Protease by SP-1 Modulation. PLoS ONE 2013; 8(2): e56661 doi: 10.1371/journal.pone.0056661
|
| 24 |
Anuradha Moirangthem, Banashree Bondhopadhyay, Mala Mukherjee, Arghya Bandyopadhyay, Narendranath Mukherjee, Karabi Konar, Shubham Bhattacharya, Anupam Basu. Simultaneous knockdown of uPA and MMP9 can reduce breast cancer progression by increasing cell-cell adhesion and modulating EMT genes. Scientific Reports 2016; 6(1) doi: 10.1038/srep21903
|
| 25 |
Yu-Xue Wang, Wei Liu, Xin-Yu Tan, Hui-Huan Tang. In vitro neuraotropic growth of cholangiocarcinoma: an experimental study. JRSM Short Reports 2013; 4(10) doi: 10.1177/2042533313476690
|
| 26 |
Eleonóra Gál, Shahram Parvaneh, Vanda Miklós, Péter Hegyi, Lajos Kemény, Zoltán Veréb, Viktória Venglovecz. Investigating the influence of taurochenodeoxycholic acid (TCDCA) on pancreatic cancer cell behavior: An RNA sequencing approach. Journal of Biotechnology 2024; 391: 20 doi: 10.1016/j.jbiotec.2024.05.010
|
| 27 |
Feng Tian, Dajiang Li, Jian Chen, Wei Liu, Lei Cai, Jianwei Li, Peng Jiang, Zipei Liu, Xin Zhao, Fei Guo, Xiaowu Li, Shuguang Wang. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma. European Journal of Cancer 2013; 49(7): 1771 doi: 10.1016/j.ejca.2012.12.015
|
| 28 |
Chao-Bin Yeh, Yung-Luen Yu, Chiao-Wen Lin, Hui-Ling Chiou, Ming-Ju Hsieh, Shun-Fa Yang. Terminalia catappa attenuates urokinase-type plasminogen activator expression through Erk pathways in Hepatocellular carcinoma. BMC Complementary and Alternative Medicine 2014; 14(1) doi: 10.1186/1472-6882-14-141
|
| 29 |
Ross C. Smith. Biliary Tract and Gallbladder Cancer. Medical Radiology 2014; : 67 doi: 10.1007/978-3-642-40558-7_5
|
| 30 |
Kanjana Assawasuparerk, Thanakorn Rawangchue, Rassameepen Phonarknguen. Scabraside D Derived from Sea Cucumber Induces Apoptosis and Inhibits Metastasis via iNOS and STAT-3 Expression in Human Cholangiocarcinoma Xenografts. Asian Pacific Journal of Cancer Prevention 2016; 17(4): 2151 doi: 10.7314/APJCP.2016.17.4.2151
|
| 31 |
Sven A. Lang, Jan Bednarsch, Katharina Joechle, Iakovos Amygdalos, Zoltan Czigany, Lara Heij, Tom F. Ulmer, Ulf P. Neumann. Prognostic biomarkers for cholangiocarcinoma (CCA): state of the art. Expert Review of Gastroenterology & Hepatology 2021; 15(5): 497 doi: 10.1080/17474124.2021.1912591
|